Information de reference pour ce titreAccession Number: | 00005650-200305000-00005.
|
Author: | Beaton, Dorcas E. BScOT, PhD
|
Institution: | From the Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, Ontario, Canada. From the Institute for Work and Health, and the Department of Occupational Therapy and the Graduate Departments of Rehabilitation Science and Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
|
Title: | |
Source: | Medical Care. 41(5):593-596, May 2003.
|
References: | 1. Available at: http://www.usewisdom.com/sayings...- ouverture dans une nouvelle fenêtre http://www.heartquotes.net/Simpl...- ouverture dans une nouvelle fenêtre. Accessed December 20, 2002.
2. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592.
3. Naylor CD, Llewellyn-Thomas HA. Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol 1994; 47: 787-795.
4. Wright JG. The minimal important difference: who's to say what is important? J Clin Epidemiol 1996; 49: 1221-1222.
5. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996; 49: 1215-1219.
6. Bellamy N, Carr A, Dougados M, et al. Towards a definition of "difference" in osteoarthritis. J Rheumatol 2001; 28: 427-430.
7. Stratford PW, Binkley J, Soloman P, et al. Defining the minimum level of detectable change for the Roland-Morris questionnaire. Phys Ther 1996; 76: 359-368.
8. Riddle DL, Stratford PW, Binkley JM. Sensitivity to change of the Roland-Morris back pain questionnaire: part 2. Phys Ther 1998; 78: 1197-1207.
9. Stucki G, Daltroy L, Katz JN, et al. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not be equal to the sum of the parts. J Clin Epidemiol 1996; 49: 711-717.
10. Hemingway H, Stafford M, Stansfield S, et al. Is the SF-36 a valid measure of change in population health? results for the Whitehall II study. BMJ 1997; 315: 1273-1279.
11. Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care 1992; 30 (Suppl 5): MS23-MS41.
12. Wells GA, Beaton DE, Shea B, et al. Minimal clinically important differences: review of methods. J Rheumatol 2001; 28: 406-412.
13. Lassere M, van der Heijde D, Johnson KR. Foundations of the minimal clinically important difference for imaging. J Rheumatol 2001; 28: 890-891.
14. Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002; 14: 109-114.
15. Farrar JT. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain 2000; 16 (Suppl 2): S106-S112.
16. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality of life research. Pharmacoeconomics 2000; 18: 419-423.
17. Kirwan J. Minimum clinically important difference: the crock of gold at the end of the rainbow? J Rheumatol 2001; 28: 439-444.
18. Stratford PW, Binkley JM, Riddle DL, et al. Sensitivity to change of the Roland-Morris back pain questionnaire: part 1. Phys Ther 1998; 78: 1186-1196.
19. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.
20. Redelmeier DA, Lorig K. Assessing the clinical importance of symptomatic improvements: an illustration in rheumatology. Arch Intern Med 1993; 153: 1337-1342.
21. Redelmeier DA, Goldstein R, Min ST, et al. Spirometry and dyspnea in patients with COPD: when small differences mean little. Chest 1996; 109: 1163-1168.
22. Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 1993; 20: 557-560.
23. Goldsmith CH, Boers M, Bombardier C, et al. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. J Rheumatol 1993; 20: 561-565.
24. Bruynesteyn K, van der Heijde D, Boers M, et al. Minimally clinically important difference in radiological progression of joint damage over one year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol 2001; 28: 904-910.
25. Redelmeier DA, Guyatt GH, Goldstein RS. On the debate over methods for estimating the clinically important difference. J Clin Epidemiol 1996; 49: 1223-1224.
26. McAlister RA, O'Connor A, Wells GA, et al. When should hypertension be treated? the different perspectives of Canadian family physicians and patients. Can Med Assoc J 2001; 163: 403-408.
27. Beaton DE, Tarasuk V, Katz JN, et al. Are you better? a qualitative study of the meaning of being better. Arthritis Care Res 2001; 7: 313-320.
28. Drummond M, O'Brien B. Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes. Health Econ 1993; 2: 205-212.
29. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 335-340.
30. Stratford PW, Finch E, Solomon P, et al. Using the Roland-Morris questionnaire to make decisions about individual patients. Physiother Can 1996; 48: 107-110.
31. Lassere M, van der Heijde D, Johnson K, et al. Robustness and generalizability of smallest detectable difference in radiological progression. J Rheumatol 2001; 28: 911-913.
32. Jacobson NS, Roberts LJ, Berns SB, et al. Methods for defining and determining the clinical significance of treatment effects: description, application, alternatives. J Consult Clin Psychol 1999; 67: 300-307.
33. Jacobson NS, Traux P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12-19.
34. Stratford PW, Riddle DL, Binkley JM, et al. Using the neck disability index to make decisions concerning individual patients. Physiother Can 1999; 51: 107-112.
35. McHorney CA, Tarlov AR. Individual patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.
36. Stratford PW, Binkley JM. Measurement properties of the RM-18: a modified version of the Roland-Morris Disability Scale. Spine 1997; 22: 2416-2421.
37. de Lemos J, Tweedale M, Chittock D, Sedation Focus Group. Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction and Calmness Scale. J Clin Epidemiol 2000; 53: 908-919.
38. Wyrwich KW, Nienaber MA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999; 37: 469-478.
39. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting standard error of measurement based criterion for identifying meaningful intra-individual change in health-related quality of life. J Clin Epidemiol 1999; 52: 861-873.
40. Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care 1992; 30 (Suppl 5): MS23-MS41.
|
Language: | English.
|
Document Type: | Point.
|
Journal Subset: | Clinical Medicine. Behavioral & Social Sciences.
|
ISSN: | 0025-7079
|
NLM Journal Code: | 0230027, lsm
|
Annotation(s) | |
|
|